tiprankstipranks
Trending News
More News >
Cue Biopharma (CUE)
:CUE
US Market

Cue Biopharma (CUE) Financial Statements

Compare
606 Followers

Cue Biopharma Financial Overview

Cue Biopharma's market cap is currently $52.76M. The company's EPS TTM is $-0.17; its P/E ratio is ―; Cue Biopharma is scheduled to report earnings on May 12, 2025, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 9.29M$ 5.49M$ 1.25M$ 14.94M$ 3.15M
Gross Profit$ 9.29M$ -32.61M$ -560.83K$ 16.72M$ -30.39M
Operating Income$ -41.50M$ -52.15M$ -53.22M$ -43.71M$ -45.04M
EBITDA$ -37.53M$ -46.05M$ -50.49M$ -45.44M$ -43.99M
Net Income$ -40.67M$ -50.73M$ -52.80M$ -44.16M$ -44.78M
Balance Sheet
Cash & Short-Term Investments$ 22.46M$ 48.51M$ 76.29M$ 64.37M$ 84.87M
Total Assets$ 32.19M$ 61.53M$ 91.28M$ 83.40M$ 99.53M
Total Debt$ 8.88M$ 14.70M$ 19.32M$ 10.05M$ 7.15M
Net Debt$ -13.58M$ -33.82M$ -32.30M$ -54.32M$ -67.72M
Total Liabilities$ 14.69M$ 24.45M$ 25.60M$ 17.91M$ 20.62M
Stockholders' Equity$ 17.50M$ 37.09M$ 65.68M$ 65.49M$ 78.91M
Cash Flow
Free Cash Flow$ -36.40M$ -39.96M$ -41.98M$ -39.75M$ -33.09M
Operating Cash Flow$ -36.33M$ -39.96M$ -41.81M$ -38.84M$ -32.49M
Investing Cash Flow$ 32.00K$ 25.00M$ -24.61M$ 9.11M$ 4.46M
Financing Cash Flow$ 10.24M$ 11.86M$ 53.66M$ 19.23M$ 58.61M
Currency in USD

Cue Biopharma Earnings and Revenue History

Cue Biopharma Debt to Assets

Cue Biopharma Cash Flow

Cue Biopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis